Sorafenib in patients with advanced biliary tract carcinoma: a phase II trial

por Bengala, C, Bertolini, F, Malavasi, N, Boni, C, Aitini, E, Dealis, C, Zironi, S, Depenni, R, Fontana, A, Del Giovane, C, Luppi, G, Conte, P
Publicado 2010

Birth characteristics and the risk of childhood rhabdomyosarcoma based on histological subtype

por Ognjanovic, S, Carozza, S E, Chow, E J, Fox, E E, Horel, S, McLaughlin, C C, Mueller, B A, Puumala, S, Reynolds, P, Von Behren, J, Spector, L
Publicado 2010

Long-term activation of the pro-coagulant response after neoadjuvant chemoradiation and major cancer surgery

por Byrne, M, Reynolds, J V, O'Donnell, J S, Keogan, M, White, B, Byrne, M, Murphy, S, Maher, S G, Pidgeon, G P
Publicado 2010

Clinical presentation and initial management of Black men and White men with prostate cancer in the United Kingdom: the PROCESS cohort study

por Evans, S, Metcalfe, C, Patel, B, Ibrahim, F, Anson, K, Chinegwundoh, F, Corbishley, C, Gillatt, D, Kirby, R, Muir, G, Nargund, V, Popert, R, Wilson, P, Persad, R, Ben-Shlomo, Y
Publicado 2010

Circulating tumour cell detection: a direct comparison between the CellSearch System, the AdnaTest and CK-19/mammaglobin RT–PCR in patients with metastatic breast cancer

por Van der Auwera, I, Peeters, D, Benoy, I H, Elst, H J, Van Laere, S J, Prové, A, Maes, H, Huget, P, van Dam, P, Vermeulen, P B, Dirix, L Y
Publicado 2010

Prostate cancer cells modulate osteoblast mineralisation and osteoclast differentiation through Id-1

por Yuen, H-F, Chiu, Y-T, Chan, K-K, Chan, Y-P, Chua, C-W, McCrudden, C M, Tang, K-H, El-Tanani, M, Wong, Y-C, Wang, X, Chan, K-W
Publicado 2010

Influence of omega-6 PUFA arachidonic acid and bone marrow adipocytes on metastatic spread from prostate cancer

por Brown, M D, Hart, C, Gazi, E, Gardner, P, Lockyer, N, Clarke, N
Publicado 2010

Class III β-tubulin expression and in vitro resistance to microtubule targeting agents

por Stengel, C, Newman, S P, Leese, M P, Potter, B V L, Reed, M J, Purohit, A
Publicado 2010

Erythropoiesis-stimulating agents in oncology: a study-level meta-analysis of survival and other safety outcomes

por Glaspy, J, Crawford, J, Vansteenkiste, J, Henry, D, Rao, S, Bowers, P, Berlin, J A, Tomita, D, Bridges, K, Ludwig, H
Publicado 2010

Genome-wide DNA methylation profiling reveals novel epigenetically regulated genes and non-coding RNAs in human testicular cancer

por Cheung, H H, Lee, T L, Davis, A J, Taft, D H, Rennert, O M, Chan, W Y
Publicado 2010

Defining patient outcomes in stage IV colorectal cancer: a prospective study with baseline stratification according to disease resectability status

por Watkins, D J, Chau, I, Cunningham, D, Mudan, S S, Karanjia, N, Brown, G, Ashley, S, Norman, A R, Gillbanks, A
Publicado 2010

Role of reactive oxygen species in brucein D-mediated p38-mitogen-activated protein kinase and nuclear factor-κB signalling pathways in human pancreatic adenocarcinoma cells

por Lau, S T, Lin, Z X, Leung, P S
Publicado 2010

Considerations for the use of plasma cytokeratin 18 as a biomarker in pancreatic cancer

por Dive, C, Smith, R A, Garner, E, Ward, T, George-Smith, S St, Campbell, F, Greenhalf, W, Ghaneh, P, Neoptolemos, J P
Publicado 2010

A novel fragment derived from the β chain of human fibrinogen, β43–63, is a potent inhibitor of activated endothelial cells in vitro and in vivo

por Krajewska, E, Lewis, C E, Chen, Y-Y, Welford, A, Tazzyman, S, Staton, C A
Publicado 2010

Trends in incidence of childhood cancer in Australia, 1983–2006

por Baade, P D, Youlden, D R, Valery, P C, Hassall, T, Ward, L, Green, A C, Aitken, J F
Publicado 2010

Combination therapy: intermittent sorafenib with bevacizumab yields activity and decreased toxicity

por Lee, J-M, Sarosy, G A, Annunziata, C M, Azad, N, Minasian, L, Kotz, H, Squires, J, Houston, N, Kohn, E C
Publicado 2010

Cetuximab plus oxaliplatin/leucovorin/5-fluorouracil in first-line metastatic gastric cancer: a phase II study of the Arbeitsgemeinschaft Internistische Onkologie (AIO)

por Lordick, F, Luber, B, Lorenzen, S, Hegewisch-Becker, S, Folprecht, G, Wöll, E, Decker, T, Endlicher, E, Röthling, N, Schuster, T, Keller, G, Fend, F, Peschel, C
Publicado 2010

Randomised, non-comparative phase II study of weekly docetaxel with cisplatin and 5-fluorouracil or with capecitabine in oesophagogastric cancer: the AGITG ATTAX trial

por Tebbutt, N C, Cummins, M M, Sourjina, T, Strickland, A, Van Hazel, G, Ganju, V, Gibbs, D, Stockler, M, Gebski, V, Zalcberg, J
Publicado 2010

Neuropilin-1 antagonism in human carcinoma cells inhibits migration and enhances chemosensitivity

por Jia, H, Cheng, L, Tickner, M, Bagherzadeh, A, Selwood, D, Zachary, I
Publicado 2010

Human recombinant anti-thyroperoxidase autoantibodies: in vitro cytotoxic activity on papillary thyroid cancer expressing TPO

por Rebuffat, S A, Morin, M, Nguyen, B, Castex, F, Robert, B, Péraldi-Roux, S
Publicado 2010